Keywords: atrix, fujisawa, healthcare, submit, nda, aczone, acne

Atrix and Fujisawa Healthcare submit NDA for Aczone for acne

Article | 06 September 2004

Print This

The USA's Atrix Laboratories and co-development partner FujisawaHealthcare have submitted a New Drug Application to the US Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in